Datta G, Miller N, Du W, Geiger J, Chang S, Chen X
J Neurosci. 2021; 41(50):10365-10381.
PMID: 34764157
PMC: 8672688.
DOI: 10.1523/JNEUROSCI.1475-21.2021.
Umotoy J, de Taeye S
Front Immunol. 2021; 12:708806.
PMID: 34276704
PMC: 8282362.
DOI: 10.3389/fimmu.2021.708806.
Sil S, Thangaraj A, Chivero E, Niu F, Kannan M, Liao K
Neurosci Lett. 2021; 754:135863.
PMID: 33794296
PMC: 8108725.
DOI: 10.1016/j.neulet.2021.135863.
Lu M, Ma X, Reichard N, Terry D, Arthos J, Smith 3rd A
J Virol. 2020; 94(17).
PMID: 32522853
PMC: 7431789.
DOI: 10.1128/JVI.00597-20.
Anand A, Rachel G, Parthasarathy D
Front Cardiovasc Med. 2019; 5:185.
PMID: 30619892
PMC: 6305718.
DOI: 10.3389/fcvm.2018.00185.
Endocytic Trafficking of HIV gp120 is Mediated by Dynamin and Plays a Role in gp120 Neurotoxicity.
Wenzel E, Bachis A, Avdoshina V, Taraballi F, Tasciotti E, Mocchetti I
J Neuroimmune Pharmacol. 2017; 12(3):492-503.
PMID: 28349243
PMC: 5815508.
DOI: 10.1007/s11481-017-9739-4.
HIV Glycoprotein Gp120 Impairs Fast Axonal Transport by Activating Tak1 Signaling Pathways.
Berth S, Mesnard-Hoaglin N, Wang B, Kim H, Song Y, Sapar M
ASN Neuro. 2016; 8(6).
PMID: 27872270
PMC: 5119683.
DOI: 10.1177/1759091416679073.
HIV-1 Structural Proteins Serve as PAMPs for TLR2 Heterodimers Significantly Increasing Infection and Innate Immune Activation.
Henrick B, Yao X, Rosenthal K
Front Immunol. 2015; 6:426.
PMID: 26347747
PMC: 4541371.
DOI: 10.3389/fimmu.2015.00426.
Effect of lysine to arginine mutagenesis in the V3 loop of HIV-1 gp120 on viral entry efficiency and neutralization.
Schwalbe B, Schreiber M
PLoS One. 2015; 10(3):e0119879.
PMID: 25785610
PMC: 4364900.
DOI: 10.1371/journal.pone.0119879.
Internalization and axonal transport of the HIV glycoprotein gp120.
Berth S, Caicedo H, Sarma T, Morfini G, Brady S
ASN Neuro. 2015; 7(1).
PMID: 25636314
PMC: 4720180.
DOI: 10.1177/1759091414568186.
HIV-1 Tat activates a RhoA signaling pathway to reduce NMDA-evoked calcium responses in hippocampal neurons via an actin-dependent mechanism.
Krogh K, Lyddon E, Thayer S
J Neurochem. 2014; 132(3):354-66.
PMID: 25156524
PMC: 4304915.
DOI: 10.1111/jnc.12936.
Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins.
Raborn E, Jamerson M, Marciano-Cabral F, Cabral G
Life Sci. 2014; 104(1-2):15-23.
PMID: 24742657
PMC: 4089388.
DOI: 10.1016/j.lfs.2014.04.008.
Flow cytometry analysis of cell population dynamics and cell cycle during HIV-1 envelope-mediated formation of syncytia in vitro.
Torres-Castro I, Cortes-Rubio C, Sandoval G, Lamoyi E, Larralde C, Huerta L
In Vitro Cell Dev Biol Anim. 2014; 50(5):453-63.
PMID: 24442370
DOI: 10.1007/s11626-013-9724-z.
Functional interaction between HIV-gp120 and opioid system in the preoptic anterior hypothalamus.
Palma J, Abood M, Barbe M, Benamar K
Drug Alcohol Depend. 2013; 134:383-386.
PMID: 24120859
PMC: 3974549.
DOI: 10.1016/j.drugalcdep.2013.09.015.
Modeling HIV-associated neurocognitive disorders in mice: new approaches in the changing face of HIV neuropathogenesis.
Jaeger L, Nath A
Dis Model Mech. 2012; 5(3):313-22.
PMID: 22563057
PMC: 3339825.
DOI: 10.1242/dmm.008763.
HIV gp120 binds to mannose receptor on vaginal epithelial cells and induces production of matrix metalloproteinases.
Fanibunda S, Modi D, Gokral J, Bandivdekar A
PLoS One. 2011; 6(11):e28014.
PMID: 22132194
PMC: 3222676.
DOI: 10.1371/journal.pone.0028014.
Activation of cannabinoid type 2 receptors inhibits HIV-1 envelope glycoprotein gp120-induced synapse loss.
Kim H, Shin A, Thayer S
Mol Pharmacol. 2011; 80(3):357-66.
PMID: 21670103
PMC: 3164336.
DOI: 10.1124/mol.111.071647.
HIV-1 gp120 induces cytokine expression, leukocyte adhesion, and transmigration across the blood-brain barrier: modulatory effects of STAT1 signaling.
Yang B, Akhter S, Chaudhuri A, Kanmogne G
Microvasc Res. 2008; 77(2):212-9.
PMID: 19103208
PMC: 3715090.
DOI: 10.1016/j.mvr.2008.11.003.
The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes.
Bukreyev A, Yang L, Fricke J, Cheng L, Ward J, Murphy B
J Virol. 2008; 82(24):12191-204.
PMID: 18842713
PMC: 2593351.
DOI: 10.1128/JVI.01604-08.
Antibody binding is a dominant determinant of the efficiency of human immunodeficiency virus type 1 neutralization.
Yang X, Lipchina I, Cocklin S, Chaiken I, Sodroski J
J Virol. 2006; 80(22):11404-8.
PMID: 16956933
PMC: 1642171.
DOI: 10.1128/JVI.01102-06.